Attached files

file filename
8-K - MODEL N, INC.rrd378804.htm

MODEL N ANNOUNCES SECOND QUARTER FISCAL 2013 FINANCIAL RESULTS

Q2 revenues of $24.6 million, a 21% year-over-year increase

Raised over $100 million in growth capital through IPO listing on the New York Stock Exchange

Redwood City, CA (May 7, 2013) - Model N, Inc., (NYSE: MODN), the leader in Revenue Management solutions for the life science and technology industries, today announced financial results for the second quarter of fiscal 2013, which ended March 31, 2013.

"We are pleased with our second quarter results, which exceeded our expectations on both revenue and profitability," said Zack Rinat, Founder, Chairman, and Chief Executive Officer at Model N. "We are still in the early stages of a major new market opportunity as companies adopt modern software solutions to address their Revenue Management challenges, replacing outdated custom solutions and manual business processes along the way. Model N has emerged as the market leader as a result of our comprehensive Revenue Management platform, vertical focus and demonstrated history of delivering business value."

"We are pleased to have completed our IPO in March. The increased market awareness and financial resources from this event will help us to execute the company's growth plans and capitalize on our growing, multi-billion dollar market opportunity," added Rinat.

Second Quarter Fiscal 2013 Financial Highlights:

  • Total Revenues: Total revenues were $24.6 million, a year-over-year increase of 21% compared to $20.2 million for the second quarter of fiscal 2012.
  • Gross Profit: Gross profit was $13.0 million, compared to $9.6 million for the second quarter of fiscal 2012. Non-GAAP gross profit was $13.3 million compared to $11.1 million for the second quarter of fiscal 2012.
  • Income (Loss) from operations: GAAP loss from operations was $1.0 million, compared to $3.7 million for the second quarter of fiscal 2012. Non-GAAP income from operations was slightly above breakeven, compared to a loss from operations of $0.8 million for the second quarter of fiscal 2012.
  • Net loss: GAAP net loss was $1.9 million, compared to $4.2 million for the second quarter of fiscal 2012. GAAP net loss per share was $0.19 based upon weighted average shares outstanding of 10.1 million, as compared to $0.54 for the second quarter of fiscal 2012 based upon weighted average shares outstanding of 7.7 million.
  • Non-GAAP net loss: Non-GAAP net loss was $0.2 million, as compared to $1.1 million for the second quarter of fiscal 2012. Non-GAAP net loss per share was $0.01 based upon weighted average shares outstanding of 16.4 million, as compared to $0.07 for the second quarter of fiscal 2012 based upon weighted average shares outstanding of 15.0 million.
  • Adjusted EBITDA: Adjusted EBITDA was $0.5 million, compared to ($0.4) million for the second quarter of fiscal 2012.

Use of Non-GAAP Financial Measures

A reconciliation of GAAP to non-GAAP financial measures has been provided in the financial statement tables included in this press release. An explanation of these measures, including the reasons management uses each measure, is also included below under the heading "Non-GAAP Financial Measures."

Quarterly Results Conference Call

Model N will host a conference call today at 2:00 PM Pacific Time (5:00 PM Eastern Time) to review the company's financial results for the second quarter of fiscal 2013, which ended March 31, 2013. To access the call, please dial (888) 503-8169 in the U.S. or (719) 325-2454 internationally. Passcode is 4807849. A live webcast of the conference will be accessible from Model N's website at: http://investor.modeln.com. Following the completion of the call through 11:59 p.m. ET on May 14, 2013, a recording will be available for replay at: http://investor.modeln.com and a telephone replay will be available by dialing (877) 870-5176 in the U.S. or (858) 384-5517 internationally with recording access code 4807849.

About Model N

Model N is the leader in Revenue Management solutions. Model N helps our customers dramatically improve pricing and contracting, rebates and incentives, and sales and marketing performance analysis to increase their revenue. Model N drives improved pricing, margin, and revenue performance for our customers through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology manufacturers in more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Forward-Looking Statements

This press release contains forward-looking statements including, among other things, statements regarding Model N's growth plans. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to: (i) adverse changes in general economic or market conditions; (ii) delays or reductions in information technology spending and resulting variability in customer orders from quarter to quarter; (iii) competitive factors, including but not limited to pricing pressures, industry consolidation, entry of new competitors and new applications and marketing initiatives by our competitors; (iv) our ability to manage our growth effectively; and (v) acceptance of our applications and services by customers. Further information on risks that could affect Model N's results is included in our filings with the Securities and Exchange Commission, including our final prospectus, our quarterly report on Form 10-Q for the quarter ended March 31, 2013, and current reports on Form 8-K that we may file from time to time. Should any of these risks or uncertainties materialize, actual results could differ materially from expectations. Model N assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release.

Non-GAAP Financial Measures

We have provided in this release financial information that has not been prepared in accordance with accounting standards generally accepted in the United States of America ("GAAP"). We use these non-GAAP financial measures internally in analyzing our financial results and believe they are useful to investors, as a supplement to GAAP measures, in evaluating our ongoing operational performance. We believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial results with other companies in our industry, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures below. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided in the financial statement tables included below in this press release.

Our reported results include certain non-GAAP financial measures, including non-GAAP operating income (loss), non-GAAP net income (loss), weighted-average shares outstanding, non-GAAP net income (loss) per share, and adjusted EBITDA. Non-GAAP operating income (loss) and non-GAAP net income (loss) exclude expenses related to stock-based compensation expense, LeapFrogRX compensation charges, amortization of intangible assets, and changes in fair value of preferred stock warrant liability as they are often excluded by other companies to help investors understand the operational performance of their business and, in the case of stock-based compensation, can be difficult to predict. In addition, stock-based compensation expense varies from period to period and company to company due to such things as differing valuation methodologies and changes in stock price. Adjusted EBITDA is defined as net income (loss), adjusted for LeapFrogRX compensation charges, depreciation and amortization, stock-based compensation expense, interest and other expense, net, and provision for income taxes. Reconciliation tables are provided in this press release.

 

Investor Relations Contact:

ICR for Model N
Greg Kleiner, 650-610-4998
investorrelations@modeln.com

Media Contact:

Model N
Kristin Lee, 650-610-4717
Marketing
klee@modeln.com

 

 

 

 

 

 Model N Inc.

Condensed Consolidated Balance Sheets

(dollars in thousands)

(unaudited)

March 31,

September 30,

2013

2012

Assets

Current assets:

Cash and cash equivalents

$ 109,024

$ 15,768

Short-term investments

63

-

Accounts receivable, net of allowances of $98 and $55 as of

March 31, 2013 and September 30, 2012, respectively

15,101

12,468

Deferred cost of implementation services, current portion

1,116

1,077

Prepaid expenses

1,621

2,246

Other current assets

327

552

Total current assets

127,252

32,111

Property and equipment, net

5,966

4,590

Goodwill

1,509

1,509

Other intangible assets, net

1,083

1,248

Other assets

711

1,140

Total assets

$ 136,521

$ 40,598

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$ 539

$ 196

Accrued employee compensation

8,045

7,650

Accrued liabilities

4,670

4,432

Deferred revenue, current portion

28,118

29,362

Capital lease obligations, current portion

519

555

Loan obligations, current portion

2,500

2,500

Total current liabilities

44,391

44,695

Long-term liabilities:

Deferred revenue, net of current portion

2,398

2,289

Capital lease obligations, net of current portion

87

349

Loan obligations, net of current portion

1,397

2,627

Other long-term liabilities

688

1,125

Total long-term liabilities

4,570

6,390

Total liabilities

48,961

51,085

Convertible preferred stock:

-

41,776

Stockholders' equity:

Common stock

3

1

Preferred stock

-

-

Additional paid-in capital

152,099

9,045

Accumulated other comprehensive loss

(144)

(120)

Accumulated deficit

(64,398)

(61,189)

Total equity

87,560

(52,263)

Total liabilities, convertible preferred stock and stockholders' equity

$ 136,521

$ 40,598

 

 

 

Model N Inc.

Condensed Consolidated Statements of Operations

(dollars and shares in thousands, except per share amounts)

(unaudited)

Three months ended

Six months ended

March 31,

March 31,

March 31,

March 31,

2013

2012

2013

2012

Revenue:

License and implementation

$ 14,481

$ 11,659

$ 26,943

$ 23,024

SaaS and maintenance

10,078

8,581

19,957

15,273

Total revenue

24,559

20,240

46,900

38,297

Cost of revenue:

License and implementation

6,800

5,515

12,360

10,543

SaaS and maintenance

4,781

5,168

9,304

7,664

Total cost of revenue

11,581

10,683

21,664

18,207

Gross profit

12,978

9,557

25,236

20,090

Operating expenses:

Research and development

4,483

4,817

8,602

8,990

Sales and marketing

5,770

5,705

11,106

9,686

General and administrative

3,758

2,773

7,635

5,166

Total operating expenses

14,011

13,295

27,343

23,842

Operating loss

(1,033)

(3,738)

(2,107)

(3,752)

Interest expense, net

115

170

241

354

Other expense, net

660

179

712

585

Loss before income taxes

(1,808)

(4,087)

(3,060)

(4,691)

Provision for income taxes

88

68

149

139

Net loss attributable to Model N Inc. common stockholders

(1,896)

(4,155)

(3,209)

(4,830)

Net loss per share attributable to Model N Inc. common stockholders

$ (0.19)

$ (0.54)

$ (0.35)

$ (0.63)

Weighted average number of shares used in computing net loss per common share

10,137

7,731

9,071

7,677

 

Model N Inc.

Condensed Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

Three months ended

Six months ended

March 31,

March 31,

2013

2012

2013

2012

Cash flows from operating activities:

Net loss

$ (1,896)

$ (4,155)

$ (3,209)

$ (4,830)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities

Depreciation and amortization

495

391

937

704

Amortization of other intangible assets

84

68

165

68

Stock-based compensation

942

1,086

1,499

1,594

Amortization of debt discount

10

11

20

21

Changes in fair value of preferred stock warrant liability

685

127

671

443

Provision for doubtful accounts

1

-

9

(10)

Deferred income taxes

34

32

59

63

Changes in operating assets and liabilities, net of

acquired assets and liabilities:

Accounts receivable

748

1,301

(2,732)

1,967

Prepaid expenses and other current assets

(151)

(302)

(1,491)

(159)

Deferred cost of implementation services

273

(217)

290

(298)

Accounts payable

(862)

1,284

307

1,593

Accrued employee compensation

449

3,231

424

1,655

Other accrued and long-term liabilities

(457)

363

1,579

601

Deferred revenue

(1,756)

(2,315)

(1,045)

2,177

Net cash provided by (used in) operating activities

(1,401)

905

(2,517)

5,589

Cash flows from investing activities:

Purchases of property and equipment

(308)

(268)

(472)

(767)

Capitalization of software development costs

(831)

-

(1,722)

-

Purchase of short-term investments

-

-

(63)

-

Acquisition of a business

-

(3,000)

-

(3,000)

Net cash used in investing activities

(1,139)

(3,268)

(2,257)

(3,767)

Cash flows from financing activities:

Proceeds from initial public offering, net of offering costs of $7.6 million

101,064

-

101,064

-

Proceeds from issuance of common stock upon exercise of stock options

423

29

513

115

Payments for deferred offering costs

(1,761)

-

(1,976)

-

Principal payments on capital lease obligations

(158)

(144)

(298)

(241)

Principal payments on loan

(625)

(625)

(1,250)

(1,042)

Net cash provided by (used in) financing activities

98,943

(740)

98,053

(1,168)

Effect of exchange rate changes on cash and cash equivalents

(12)

22

(23)

(15)

Net change in cash and cash equivalents

96,391

(3,081)

93,256

639

Cash and cash equivalents at beginning of period

12,633

22,140

15,768

18,420

Cash and cash equivalents at end of period

$ 109,024

$ 19,059

$ 109,024

$ 19,059

 

 

 

 

Model N Inc.

Reconciliation of GAAP to Non-GAAP Operating Results

(dollars and shares in thousands, except per share amounts)

(unaudited)

Three months ended

March 31,

Six months ended

March 31,

2013

2012

2013

2012

Reconciliation from GAAP net income (loss) to adjusted EBITDTA

GAAP net income (loss):

$ (1,896)

$ (4,155)

$ (3,209)

$ (4,830)

Reversal of non-GAAP expenses:

Stock-based compensation

942

1,086

1,499

1,594

Depreciation and amortization

578

459

1,102

772

Interest expense, net

115

170

241

354

Other expense, net

660

179

712

585

LeapFrogRx compensation charges

25

1,789

414

1,789

Provision for income taxes

88

68

149

139

Adjusted EBITDA

$ 512

$ (404)

$ 908

$ 403

Three months ended

March 31,

Six months ended

March 31,

2013

2012

2013

2012

Reconciliation from GAAP total gross profit to non-GAAP total gross profit:

GAAP gross profit:

$ 12,978

$ 9,557

$ 25,236

$ 20,090

Reversal of non-GAAP expenses:

Stock-based compensation (a)

204

437

318

538

Amortization of intangible assets (b)

61

50

121

50

LeapFrogRx compensation charges (c)

16

1,092

257

1,092

Non-GAAP gross profit

$ 13,259

$ 11,136

$ 25,932

$ 21,770

Percentage of revenue

54.0%

55.0%

55.3%

56.8%

Three months ended

March 31,

Six months ended

March 31,

2013

2012

2013

2012

Reconciliation from GAAP gross profit to non-GAAP gross profit:

for license and implementation:

GAAP gross profit - license and implementation:

$ 7,681

$ 6,144

$ 14,583

$ 12,481

Reversal of non-GAAP expenses:

Stock-based compensation (a)

90

69

130

146

Non-GAAP gross profit - license and implementation

$ 7,771

$ 6,213

$ 14,713

$ 12,627

Percentage of revenue

53.7%

53.3%

54.6%

54.8%

Three months ended

March 31,

Six months ended March 31,

2013

2012

2013

2012

Reconciliation from GAAP gross profit to non-GAAP gross profit:

for SaaS and maintenance:

GAAP gross profit - SaaS and maintenance:

$ 5,297

$ 3,413

$ 10,653

$ 7,609

Reversal of non-GAAP expenses:

Stock-based compensation (a)

114

368

188

392

Amortization of intangible assets (b)

61

50

121

50

LeapFrogRx compensation charges (c)

16

1,092

257

1,092

Non-GAAP gross profit - SaaS and maintenance

$ 5,488

$ 4,923

$ 11,219

$ 9,143

Percentage of revenue

54.5%

57.4%

56.2%

59.9%

Three months ended

March 31,

Six months ended March 31,

2013

2012

2013

2012

Reconciliation from GAAP research and development to non-GAAP research and development:

GAAP research and development:

$ 4,483

$ 4,817

$ 8,602

$ 8,990

Reversal of non-GAAP expenses:

Stock-based compensation (a)

(98)

(73)

(152)

(170)

LeapFrogRx compensation charges (c)

(4)

(34)

(31)

(34)

Non-GAAP research and development

$ 4,381

$ 4,710

$ 8,419

$ 8,786

Three months ended March 31,

Six months ended March 31,

2013

2012

2013

2012

Reconciliation from GAAP sales and marketing to non-GAAP sales and marketing:

GAAP sales and marketing:

$ 5,770

$ 5,705

$ 11,106

$ 9,686

Reversal of non-GAAP expenses:

Stock-based compensation (a)

(454)

(529)

(713)

(774)

Amortization of intangible assets (b)

(22)

(18)

(43)

(18)

LeapFrogRx compensation charges (c)

(4)

(427)

(88)

(427)

Non-GAAP sales and marketing

$ 5,290

$ 4,731

$ 10,262

$ 8,467

Three months ended March 31,

Six months ended March 31,

2013

2012

2013

2012

Reconciliation from GAAP general and administrative to non-GAAP general and administrative:

GAAP general and administrative:

$ 3,758

$ 2,773

$ 7,635

$ 5,166

Reversal of non-GAAP expenses:

Stock-based compensation (a)

(186)

(47)

(316)

(112)

LeapFrogRx compensation charges (c)

(1)

(236)

(38)

(236)

Non-GAAP general and administrative

$ 3,571

$ 2,490

$ 7,281

$ 4,818

Three months ended March 31,

Six months ended March 31,

2013

2012

2013

2012

Reconciliation from GAAP operating loss to non-GAAP operating income (loss):

GAAP operating loss:

$ (1,033)

$ (3,738)

$ (2,107)

$ (3,752)

Reversal of non-GAAP expenses:

Stock-based compensation (a)

942

1,086

1,499

1,594

Amortization of intangible assets (b)

83

68

164

68

LeapFrogRx compensation charges (c)

25

1,789

414

1,789

Non-GAAP operating income (loss)

$ 17

$ (795)

$ (30)

$ (301)

Three months ended March 31,

Six months ended March 31,

2013

2012

2013

2012

Numerator:

Reconciliation between GAAP and non-GAAP net loss:

GAAP net loss:

$ (1,896)

$ (4,155)

$ (3,209)

$ (4,830)

Reversal of non-GAAP expenses:

Stock-based compensation (a)

942

1,086

1,499

1,594

Changes in fair value of preferred stock warrant liability (d)

685

127

671

443

Amortization of intangible assets (b)

83

68

164

68

LeapFrogRx compensation charges (c)

25

1,789

414

1,789

Non-GAAP net loss attributable to Model N Inc. common stockholders

$ (161)

$ (1,085)

$ (461)

$ (936)

Denominator:

Reconciliation between GAAP and non-GAAP weighted average shares used in computing

diluted net loss per common share:

Weighted average number of shares used in computing net loss per common share

10,137

7,731

9,071

7,677

Assuming the conversion of preferred stock at the beginning of each period

6,284

7,250

6,772

7,250

Non-GAAP weighted average shares used in computing non-GAAP

net loss per common share

16,421

14,981

15,843

14,927

GAAP net loss per share attributable to Model N Inc. common stockholders

$ (0.19)

$ (0.54)

$ (0.35)

$ (0.63)

Non-GAAP net loss per share attributable to Model N Inc. common stockholders

$ (0.01)

$ (0.07)

$ (0.03)

$ (0.06)

Use of Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements presented on a GAAP basis, Model N uses non-GAAP measures of adjusted EBITDA, net loss, weighted average shares outstanding and net loss per share, which are adjusted to exclude LeapFrogRx compensation charges, stock-based compensation expense, amortization of intangible assets and changes in fair value of preferred stock warrant liability and includes dilutive shares where applicable. We believe these adjustments are appropriate to enhance an overall understanding of our past financial performance and also our prospects for the future. These adjustments to our current period GAAP results are made with the intent of providing both management and investors a more complete understanding of Model N's underlying operating results and trends and our marketplace performance. The non-GAAP results are an indication of our baseline performance that are considered by management for the purpose of making operational decisions. In addition, these non-GAAP results are the primary indicators management uses as a basis for our planning and forecasting of future periods. The presentation of this additional information is not meant to be considered in isolation or as a substitute for operating loss, net loss or basic and diluted net loss per share prepared in accordance with generally accepted accounting principles in the United States. Non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles and are subject to limitations.

While a large component of our expense in certain periods, we believe investors may want to exclude the effects of these items in order to compare our financial performance with that of other companies and between time periods:

(a)

Stock-based compensation is a non-cash expense accounted for in accordance with FASB ASC Topic 718. Share-based compensation expenses are excluded from our non-GAAP income because share-based compensation amounts are difficult to forecast due in part to the volume and timing of stock option and restricted stock grants and the volatility our common stock. We believe that the exclusion of stock-based compensation expense provides for a better comparison of our operation results to prior periods and to our peer companies.

(b)

Amortization of intangible assets resulted principally from acquisitions. Intangible asset amortization is a non-cash item. As such, we believe exclusion of these expenses provides for a better comparison of our operation results to prior periods and to our peer companies.

(c)

In January 2012, we acquired LeapFrog Rx for initial cash consideration of $3.0 million as well as potential additional payments to former LeapFrogRx shareholders totalling upto $8.3 million which are expected to be incurred through January 2015. These additional payments are, among other things, subject to future continued employment and are therefore considered compensatory in nature and are being recognized as compensation expense (LeapFrogRx compensation charges) over the term of each component. We believe that the exclusion of these expenses provides for a better comparison of our operation results to prior periods and to our peer companies.

(d)

Preferred stock warrant was classified as liability and was marked to market in each period until the preferred stock warrant was converted to common stock warrant upon the closing date of IPO. The change in fair value of preferred stock warrant liability was a non-cash item. We believe that the exclusion of this expense provides for a better comparison of our operation results to prior periods and to our peer companies.